
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Primary cutaneous follicle centre lymphoma epidemiology and demographics
Introduction
Overview
Overview
The incidence of primary cutaneous follicle centre lymphoma increases with age; the median age at diagnosis is 51 years. Males are more commonly affected with primary cutaneous follicle centre lymphoma than females.[1]
Epidemiology and Demographics
Epidemiology and Demographics
According to a large population-based study focused on cutaneous lymphomas (CL) in the United States by Bradford et al. on 3884 Cutaneous lymphomas 9CLs) diagnosed during 2001-2005. Cutaneous T-cell lymphomas (CTCLs) accounted for 71% (age-adjusted incidence rate [IR] = 7.7/1 000 000 person-years), whereas cutaneous B-cell lymphomas(CBCLs) accounted for 29% (IR = 3.1/1 000 000 person-years).[2]
Incidence
- Over the past 25 years, the CL incidence rate increased from 5.0/1 000 000 person-years during 1980-1982 to 14.3 during 2001-2003.
- During 2004-2005, the CL IR was 12.7. This recent apparent change could be incomplete case ascertainment or potential levelling off of incidence rates.
- CLs rates vary markedly by race and sex, supporting the notion that they represent distinct disease entities.
Prevalence
- There is no prevalence report primary cutaneous follicle centre lymphoma.
- Primary cutaneous follicle center lymphoma is the most common primary cutaneous B-cell lymphoma.
- It accounts for approximately 10% to 20% of all cutaneous lymphomas and comprises about 50% of primary cutaneous B-cell lymphomas.
Case-fatality rate/Mortality rate
- The case-fatality rate/mortality rate of primary cutaneous follicle centre lymphoma is quite low.
- Spread from the skin is unusual, and the prognosis is excellent with a 5-year survival of over 97%.
- The International Extranodal Lymphoma Study Group identified elevated LDH, more than two skin lesions, and nodular lesions as three prognostic factors, that are used to assess a cutaneous lymphoma international prognostic index (CLIPI), which is prognostic of disease-free status.
Age
- The incidence of primary cutaneous follicle centre lymphoma increases with age; the median age at diagnosis is 51 years.[1]
- Most commonly, patients are white men, 50 to 60 years old, although younger patients and women may also develop this lymphoma.
Race
- Primary cutaneous follicle centre lymphoma usually affects individuals of the blacks and non-Hispanic whites followed by Hispanic whites and Asian/Pacific Islanders . Whites of European descent individuals are less likely to develop primary cutaneous follicle centre lymphoma.
- According to Bradford et al. CL incidence rate were highest among blacks and non-Hispanic whites (both 11.5/1 000 000 person-years), followed by Hispanic whites (7.9) and Asian/Pacific Islanders (7.1). The CTCL IR was highest among blacks (10.0/1 000 000 person-years), whereas the CBCL IR was highest among non-Hispanic whites (3.5).[2]
Gender
Males are more commonly affected with primary cutaneous follicle centre lymphoma than females.[1]
According to Bradford et al. also, males had a statistically significant higher incidence of CL than females (14.0 vs 8.2/1 000 000 person-years, respectively; male-female IR ratio [M/F IRR] = 1.72; P < .001).[2]
Region
- Theoretically, and according to some studies primary cutaneous follicle centre lymphoma cases are more reported in areas of increased prevalence of the following pathogenes:
- Specifically, the region of southeast Asian countries have a presumable high incidence of cutaneous T cell Lymphoma(CTCL), in particular, Epstein-Baar virus-associated natural killer/T-cell lymphomas, while Cutaneous B cell lymphomas (CBCL) are very uncommon.[3]
Developed Countries
Developing Countries
References
References
- ↑ 1.0 1.1 1.2 Primary cutaneous follicle centre lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf5ae3e27c3994bd549b/. Accessed on March 01, 2016
- ↑ 2.0 2.1 2.2 Bradford PT, Devesa SS, Anderson WF, Toro JR (2009). “Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases”. Blood. 113 (21): 5064–73. doi:10.1182/blood-2008-10-184168. PMC 2686177. PMID 19279331.
- ↑ Petković IZ, Pejčić I, Tiodorović D, Krstić M, Stojnev S, Vrbić S (2017). “Transformation of primary cutaneous follicle centre lymphoma into primary cutaneous diffuse large B-cell lymphoma of other type”. Postepy Dermatol Alergol. 34 (6): 625–628. doi:10.5114/pdia.2017.66625. PMC 5799751. PMID 29422831.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2] Soroush Seifirad, M.D.[3]
